These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12238919)

  • 1. A sorbitol dehydrogenase inhibitor of exceptional in vivo potency with a long duration of action: 1-(R)-[4-[4-(4,6-dimethyl[1,3,5]triazin-2-yl)- 2R,6S-dimethylpiperazin-1-yl]pyrimidin-2- yl]ethanol.
    Mylari BL; Oates PJ; Zembrowski WJ; Beebe DA; Conn EL; Coutcher JB; O'Gorman MT; Linhares MC; Withbroe GJ
    J Med Chem; 2002 Sep; 45(20):4398-401. PubMed ID: 12238919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of a novel family of triazine-based inhibitors of sorbitol dehydrogenase with oral activity: 1-[4-[3R,5S-dimethyl-4-(4-methyl-[1,3,5]triazin-2-yl)-piperazin-1-yl]-[1,3,5]triazin-2-yl]-(R) ethanol.
    Mylari BL; Withbroe GJ; Beebe DA; Brackett NS; Conn EL; Coutcher JB; Oates PJ; Zembrowski WJ
    Bioorg Med Chem; 2003 Sep; 11(19):4179-88. PubMed ID: 12951149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orally-effective, long-acting sorbitol dehydrogenase inhibitors: synthesis, structure-activity relationships, and in vivo evaluations of novel heterocycle-substituted piperazino-pyrimidines.
    Chu-Moyer MY; Ballinger WE; Beebe DA; Berger R; Coutcher JB; Day WW; Li J; Mylari BL; Oates PJ; Weekly RM
    J Med Chem; 2002 Jan; 45(2):511-28. PubMed ID: 11784155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorbitol dehydrogenase inhibitors (SDIs): a new potent, enantiomeric SDI, 4-[2-1R-hydroxy-ethyl)-pyrimidin-4-yl]piperazine-1-sulfonic acid dimethylamide.
    Mylari BL; Oates PJ; Beebe DA; Brackett NS; Coutcher JB; Dina MS; Zembrowski WJ
    J Med Chem; 2001 Aug; 44(17):2695-700. PubMed ID: 11495581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a sorbitol dehydrogenase inhibitor on diabetic peripheral nerve metabolism: a prevention study.
    Obrosova IG; Fathallah L; Lang HJ; Greene DA
    Diabetologia; 1999 Oct; 42(10):1187-94. PubMed ID: 10525658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR and species/stereo-selective metabolism of the sorbitol dehydrogenase inhibitor, CP-470,711.
    Chu-Moyer MY; Ballinger WE; Beebe DA; Coutcher JB; Day WW; Li J; Oates PJ; Weekly RM
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1477-80. PubMed ID: 12031323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in streptozocin-induced diabetic rats.
    Tilton RG; Chang K; Nyengaard JR; Van den Enden M; Ido Y; Williamson JR
    Diabetes; 1995 Feb; 44(2):234-42. PubMed ID: 7859946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A highly selective, non-hydantoin, non-carboxylic acid inhibitor of aldose reductase with potent oral activity in diabetic rat models: 6-(5-chloro-3-methylbenzofuran- 2-sulfonyl)-2-H-pyridazin-3-one.
    Mylari BL; Armento SJ; Beebe DA; Conn EL; Coutcher JB; Dina MS; O'Gorman MT; Linhares MC; Martin WH; Oates PJ; Tess DA; Withbroe GJ; Zembrowski WJ
    J Med Chem; 2003 Jun; 46(12):2283-6. PubMed ID: 12773033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of sorbitol dehydrogenase exacerbates autonomic neuropathy in rats with streptozotocin-induced diabetes.
    Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Parvin CA; Yarasheski KE; Smith SR; Lang HJ; Williamson JR; Ido Y
    J Neuropathol Exp Neurol; 2001 Dec; 60(12):1153-69. PubMed ID: 11764088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticataract activity of analogs of a sorbitol dehydrogenase inhibitor.
    Kador PF; Inoue J; Blessing K
    J Ocul Pharmacol Ther; 2004 Aug; 20(4):333-44. PubMed ID: 15321028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversible inhibition of sheep liver sorbitol dehydrogenase by the antidiabetogenic drug 2-hydroxymethyl-4-(4-N,N-dimethylaminosulfonyl-1-piperazino) pyrimidine.
    Lindstad RI; McKinley-McKee JS
    FEBS Lett; 1997 May; 408(1):57-61. PubMed ID: 9180268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of sorbitol dehydrogenase inhibition on sugar cataract formation in galactose-fed and diabetic rats.
    Kador PF; Inoue J; Secchi EF; Lizak MJ; Rodriguez L; Mori K; Greentree W; Blessing K; Lackner PA; Sato S
    Exp Eye Res; 1998 Aug; 67(2):203-8. PubMed ID: 9733586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 1-(1,3,5-triazin-2-yl)piperidine-4-carboxamides as inhibitors of soluble epoxide hydrolase.
    Thalji RK; McAtee JJ; Belyanskaya S; Brandt M; Brown GD; Costell MH; Ding Y; Dodson JW; Eisennagel SH; Fries RE; Gross JW; Harpel MR; Holt DA; Israel DI; Jolivette LJ; Krosky D; Li H; Lu Q; Mandichak T; Roethke T; Schnackenberg CG; Schwartz B; Shewchuk LM; Xie W; Behm DJ; Douglas SA; Shaw AL; Marino JP
    Bioorg Med Chem Lett; 2013 Jun; 23(12):3584-8. PubMed ID: 23664879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sorbitol pathway of glucose metabolism in streptozotocin diabetes of varying duration and severity].
    Efimov AS; Obrosova IG; Velikiĭ NN
    Probl Endokrinol (Mosk); 1984; 30(2):71-6. PubMed ID: 6425821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling studies on the binding of substrate and inhibitor to the active site of human sorbitol dehydrogenase.
    Darmanin C; El-Kabbani O
    Bioorg Med Chem Lett; 2000 May; 10(10):1101-4. PubMed ID: 10843227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling studies of the active site of human sorbitol dehydrogenase: an approach to structure-based inhibitor design of the enzyme.
    Darmanin C; El-Kabbani O
    Bioorg Med Chem Lett; 2001 Dec; 11(24):3133-6. PubMed ID: 11720859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sorbitol dehydrogenase inhibition on experimental diabetic autonomic neuropathy.
    Schmidt RE; Dorsey DA; Beaudet LN; Plurad SB; Williamson JR; Ido Y
    J Neuropathol Exp Neurol; 1998 Dec; 57(12):1175-89. PubMed ID: 9862641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sorbitol dehydrogenase deficiency on nerve conduction in experimental diabetic mice.
    Ng TF; Lee FK; Song ZT; Calcutt NA; Lee AY; Chung SS; Chung SK
    Diabetes; 1998 Jun; 47(6):961-6. PubMed ID: 9604875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors.
    Paquin I; Raeppel S; Leit S; Gaudette F; Zhou N; Moradei O; Saavedra O; Bernstein N; Raeppel F; Bouchain G; Fréchette S; Woo SH; Vaisburg A; Fournel M; Kalita A; Robert MF; Lu A; Trachy-Bourget MC; Yan PT; Liu J; Rahil J; MacLeod AR; Besterman JM; Li Z; Delorme D
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1067-71. PubMed ID: 18160287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.